EUROPEAN JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2022-12-11 ms3000001872426513 来自河南省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤免疫
经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！

3 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2023-02-19 1e1d9025m73(暂无匿称) 来自浙江省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;临床
经验分享：投稿1个多月了，还是under review, 心理焦急

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2022-02-20 一只虫虫

审稿速度:4.0 | 投稿命中率:25.0
偏重的研究方向：癌症;肿瘤;临床
经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新

106 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2022-06-07 ms6000001244498457

with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。

68 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2022-09-19 124d2c45m98暂无昵称

审稿速度如何

62 0

[GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2022-03-31 左手摸机

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢

64 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2021-10-18 喵了个咪5371

投稿一个月还是with editor，这是什么情况啊

105 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2022-05-07 ms8000001880702144

想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？

64 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2022-04-22 12282f4cm46(暂无昵称)

审稿速度:12.0 | 投稿命中率:25.0
经验分享：审稿真的非常慢

70 0

[GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089073, encodeId=240920890e3f2, content=审稿速度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Sep 19 19:14:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213420, encodeId=8f39121342071, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：审稿真的非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a6b2337528, createdName=12282f4cm46(暂无昵称), createdTime=Fri Apr 22 12:50:55 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=)]

2022-03-14 122220a4m01暂无昵称

偏重的研究方向：肿瘤
经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？

66 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务